|
Orthologous residues
|
|
Spinophilin (human): G175‑p, Spinophilin (mouse): G177‑p, Spinophilin (rat): S177‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mass spectrometry, peptide sequencing, phospho-antibody, phosphopeptide mapping
|
|
Relevant cell lines - cell types - tissues:
'neuron, neostriatal'-brain, 293 (epithelial) [Spinophilin (rat)]
|
|
Cellular systems studied:
cell lines, primary cultured cells
|
|
Species studied:
rat
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
forskolin
|
|
|
|
increase
|
|
|
SKF81297
|
|
|
|
increase
|
|
|
quinpirole
|
|
|
|
no change compared to control
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|
|
Comments:
Phospho S177 is enriched in the cytosol and absent in PSDs.
|